非典型的ADCY5相关的运动障碍:突出青少年/成人发病的宫 dystonia
Floriane Quazza1, Florence Riant2, Martina Patera3
1Service De Neurologie Pédiatrique, Centre De Référence De Neurogénétique, Hôpital Armand Trousseau AP-HP, Sorbonne Université, Fhu I2-D2, France.
ADCY5基因突变导致运动障碍. 这项研究确定了新的表型,包括成人发作的震和宫 dystonia,以及儿科病例的自发缓解,扩大已知的ADCY5相关运动障碍谱.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 与ADCY5相关的运动障碍通常表现为神经动障碍 (PxDs) 或静态高运动障碍.
- 夜间PxD和面部/外围运动障碍表明ADCY5突变.
- 下一代测序已经扩大了对ADCY5表型的理解.
研究的目的:
- 报告与ADCY5基因突变相关的非典型表型.
- 扩大ADCY5相关运动障碍的临床和遗传谱.
主要方法:
- 临床病例系列.临床病例系列.
- 来自8个家庭的13名患者的基因分析.
- 表型特征,包括发病,症状和治疗反应.
主要成果:
- 十名患者呈现了青少年/成人发作头部和上肢震,随后是宫 dystonia,没有PxD.
- 在催化域中发现了三种新的ADCY5变异.
- 毒素是有效的;咖啡因对震无效.
- 两名患者经历了儿科发病PxD的自发缓解.
结论:
- 突出显示了头和宫 dystonia 的青少年/成人发病表型,扩大了宫 dystonia 的遗传谱.
- 儿科ADCY5-PxD表型得到扩大,有新报告的自发缓解病例.
更多相关视频
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
09:51Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
Published on: January 29, 2015
相关概念视频
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Parkinson's Disease: Overview
Mechanism of Ciliary Motion
The cilia are made up of microtubules in a 9+2 arrangement, with nine microtubule doublet ring bundles, surrounding a pair of central singlet microtubule bundles. The doublet microtubule bundles are...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
